Advertisement

Topics

Health insurer Anthem eases restrictions on Sarepta's Duchenne treatment

06:01 EST 9 Nov 2017 | Reuters

NEW YORK (Reuters) - Health insurer Anthem Inc has eased access to Sarepta Therapeutics' treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to "medically necessary."

Original Article: Health insurer Anthem eases restrictions on Sarepta's Duchenne treatment

NEXT ARTICLE

More From BioPortfolio on "Health insurer Anthem eases restrictions on Sarepta's Duchenne treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...